By |

Profile

Achaogen Inc is a biopharmaceutical company developing novel antibacterial treatments against multi-drug resistant gram-negative infections. The company is researching and developing on its product plazomicin used for the treatment of serious bacterial infections. It's another antibacterial candidate, C-Scape treats patients with urinary tract infections. All of the company's revenue is generated from government contracts for research and development in the United States.

Contact Information

Website: www.achaogen.com
Email: mforrest@achaogen.com
Main Phone: +1 650 800-3636
Address: 1 Tower Place
Address 2: Suite 300
State: CA
City / Town: South San Francisco
Country: USA
Postal Code: 94080

Issuer Information

Exchange: NSD
CEO: Blake Wise
Employees: 234
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Achaogen Inc is a biopharmaceutical company developing novel antibacterial treatments against multi-drug resistant gram-negative infections. The company is researching and developing on its product plazomicin used for the treatment of serious bacterial infections. It's another antibacterial candidate, C-Scape treats patients with urinary tract infections. All of the company's revenue is generated from government contracts for research and development in the United States.

Contact Information

Website: www.achaogen.com
Email: mforrest@achaogen.com
Main Phone: +1 650 800-3636
Address: 1 Tower Place
Address 2: Suite 300
State: CA
City / Town: South San Francisco
Country: USA
Postal Code: 94080

Issuer Information

Exchange: NSD
CEO: Blake Wise
Employees: 234
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 1.31 $ 0.0201 (1.56%)
Last Price 1.31 Change $ 0.0201 Change % 1.56 Tick N/A
Bid 1.31 Bid Size 100.00 Ask 1.32 Ask Size 500.00
Open 1.29 High 1.39 Low 1.26 Prev Close 1.29
Last Trade Volume 282,981 52 Wk Hi 15.00 52 Wk Low 1.14
Market Cap 59.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 45,712,510.00 EPS (TTM) -4.14 PE Ratio N/A Exchange NSD
  Last 3 Mo Last 12 Mo
Number of Insider Trades 15 40
Number of Buys 15 32
Number of Sells 0 8
Net Activity 1833074 2705552
Last 10 Buys Shares
Robert W. Duggan 1,000
Robert W. Duggan 1,000
Robert W. Duggan 1,000
Robert W. Duggan 1,000
Robert W. Duggan 1,000
Robert W. Duggan 1,000
Robert W. Duggan 1,000
Robert W. Duggan 1,000
Robert W. Duggan 1,000
Robert W. Duggan 1,000
Last 10 Sell Shares
Kenneth J. Hillan 1,000
Tobin Schilke 1,000
Kenneth J. Hillan 1,000
Blake Wise 1,000
Lee Swem 1,000
Blake Wise 1,000
Gary Loeb 1,000
Lee Swem 1,000
Tobin Schilke 1,000
Kenneth J. Hillan 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 28 28 28 28
Low Target Price Estimate 16 16 16 16
Mean Target Price Estimate 20.38 20.38 20.38 20.38
Standard Deviation 3.58 3.58 3.58 3.58
Date of Most Recent Estimate 05/10/18 05/10/18 05/10/18 05/10/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 9 9 9 9
Moderate Buy 1 1 1 1
Hold 1 1 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.27 1.27 1.1 1.1